Amgen, Inc. (AMGN) Tops Q2 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Amgen (AMGN) PT Raised to $135 at BMO Capital
July 30, 2014 9:11 AM EDTBMO Capital analyst Jim Birchenough reiterated a Market Perform rating and bumped his price target on Amgen (NASDAQ: AMGN) to $135.00 (from $125.00) following Q2 results
Birchenough comments, "While AMGN continues to execute well on generating a return from legacy products, we believe that transformational growth... More
Amgen (AMGN) PT, Estimates Raised at Piper Jaffray Following 'Robust' Q2
July 30, 2014 9:07 AM EDTPiper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and boosted his price target on Amgen (NASDAQ: AMGN) to $150.00 (from $143.00) following "robust" Q2 results after the close.
Schimmer comments, "AMGN reported a robust 2Q after the close, with total revenue of $5.18B... More
